DZ2383A1 - Procédé pour la cristallisation d'un dérivé de tétrahydropyridine et formes cristallines ainsi obtenues - Google Patents
Procédé pour la cristallisation d'un dérivé de tétrahydropyridine et formes cristallines ainsi obtenuesInfo
- Publication number
- DZ2383A1 DZ2383A1 DZ970233A DZ970233A DZ2383A1 DZ 2383 A1 DZ2383 A1 DZ 2383A1 DZ 970233 A DZ970233 A DZ 970233A DZ 970233 A DZ970233 A DZ 970233A DZ 2383 A1 DZ2383 A1 DZ 2383A1
- Authority
- DZ
- Algeria
- Prior art keywords
- crystallization
- crystalline forms
- tetrahydropyridine derivative
- tetrahydropyridine
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Toxicology (AREA)
- Nutrition Science (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9615904A FR2757543B1 (fr) | 1996-12-23 | 1996-12-23 | Procede pour la cristallisation d'un derive de tetrahydropyridine et formes cristallines ainsi obtenues |
Publications (1)
Publication Number | Publication Date |
---|---|
DZ2383A1 true DZ2383A1 (fr) | 2002-12-28 |
Family
ID=9499043
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DZ970233A DZ2383A1 (fr) | 1996-12-23 | 1997-12-22 | Procédé pour la cristallisation d'un dérivé de tétrahydropyridine et formes cristallines ainsi obtenues |
Country Status (39)
Country | Link |
---|---|
EP (1) | EP0950050B1 (ru) |
JP (2) | JP4499188B2 (ru) |
KR (1) | KR100586670B1 (ru) |
CN (1) | CN1129580C (ru) |
AR (1) | AR009672A1 (ru) |
AT (1) | ATE307802T1 (ru) |
AU (1) | AU736697B2 (ru) |
BR (1) | BR9714081A (ru) |
CA (1) | CA2275596C (ru) |
CO (1) | CO5070688A1 (ru) |
CZ (1) | CZ296689B6 (ru) |
DE (1) | DE69734460T2 (ru) |
DK (1) | DK0950050T3 (ru) |
DZ (1) | DZ2383A1 (ru) |
EE (1) | EE04188B1 (ru) |
EG (1) | EG21567A (ru) |
ES (1) | ES2251038T3 (ru) |
FR (1) | FR2757543B1 (ru) |
HK (1) | HK1024002A1 (ru) |
HR (1) | HRP970699B1 (ru) |
HU (1) | HU227425B1 (ru) |
IL (1) | IL129938A (ru) |
IN (1) | IN186976B (ru) |
IS (1) | IS2357B (ru) |
MY (1) | MY118015A (ru) |
NO (1) | NO312364B1 (ru) |
NZ (1) | NZ336130A (ru) |
PL (1) | PL190494B1 (ru) |
RS (1) | RS49882B (ru) |
RU (1) | RU2192416C2 (ru) |
SA (1) | SA98180971B1 (ru) |
SI (1) | SI0950050T1 (ru) |
SK (1) | SK285088B6 (ru) |
TR (1) | TR199901363T2 (ru) |
TW (1) | TW518322B (ru) |
UA (1) | UA60324C2 (ru) |
UY (1) | UY24825A1 (ru) |
WO (1) | WO1998028271A1 (ru) |
ZA (1) | ZA9711576B (ru) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2757543B1 (fr) * | 1996-12-23 | 1999-04-02 | Sanofi Sa | Procede pour la cristallisation d'un derive de tetrahydropyridine et formes cristallines ainsi obtenues |
FR2782082B3 (fr) * | 1998-08-05 | 2000-09-22 | Sanofi Sa | Formes cristallines de (r)-(+)-n-[[3-[1-benzoyl-3-(3,4- dichlorophenyl)piperidin-3-yl]prop-1-yl]-4-phenylpiperidin-4 -yl]-n-methylacetamide (osanetant) et procede pour la preparation dudit compose |
WO2011111857A1 (ja) | 2010-03-12 | 2011-09-15 | 株式会社日本触媒 | 吸水性樹脂の製造方法 |
ES2604405T3 (es) * | 2011-04-15 | 2017-03-06 | Emcure Pharmaceuticals Limited | Un procedimiento para rilpivirina mejorado |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2531707A1 (fr) * | 1982-08-16 | 1984-02-17 | Midy Spa | Trifluoromethylphenyltetrahydropyridines substituees a activite anorexigene, un procede de preparation et compositions pharmaceutiques |
FR2757543B1 (fr) * | 1996-12-23 | 1999-04-02 | Sanofi Sa | Procede pour la cristallisation d'un derive de tetrahydropyridine et formes cristallines ainsi obtenues |
-
1996
- 1996-12-23 FR FR9615904A patent/FR2757543B1/fr not_active Expired - Fee Related
-
1997
- 1997-12-19 AR ARP970106029A patent/AR009672A1/es not_active Application Discontinuation
- 1997-12-22 DZ DZ970233A patent/DZ2383A1/xx active
- 1997-12-22 MY MYPI97006233A patent/MY118015A/en unknown
- 1997-12-22 HR HR970699A patent/HRP970699B1/xx not_active IP Right Cessation
- 1997-12-23 CN CN97180863A patent/CN1129580C/zh not_active Expired - Fee Related
- 1997-12-23 IL IL12993897A patent/IL129938A/en not_active IP Right Cessation
- 1997-12-23 AT AT97952986T patent/ATE307802T1/de active
- 1997-12-23 PL PL97334256A patent/PL190494B1/pl not_active IP Right Cessation
- 1997-12-23 CZ CZ0229299A patent/CZ296689B6/cs not_active IP Right Cessation
- 1997-12-23 ZA ZA9711576A patent/ZA9711576B/xx unknown
- 1997-12-23 EE EEP199900264A patent/EE04188B1/xx not_active IP Right Cessation
- 1997-12-23 AU AU56684/98A patent/AU736697B2/en not_active Ceased
- 1997-12-23 CO CO97074792A patent/CO5070688A1/es unknown
- 1997-12-23 UA UA99063521A patent/UA60324C2/ru unknown
- 1997-12-23 KR KR1019997005373A patent/KR100586670B1/ko not_active IP Right Cessation
- 1997-12-23 EP EP97952986A patent/EP0950050B1/fr not_active Expired - Lifetime
- 1997-12-23 ES ES97952986T patent/ES2251038T3/es not_active Expired - Lifetime
- 1997-12-23 RU RU99116597/04A patent/RU2192416C2/ru not_active IP Right Cessation
- 1997-12-23 JP JP52848198A patent/JP4499188B2/ja not_active Expired - Fee Related
- 1997-12-23 DE DE69734460T patent/DE69734460T2/de not_active Expired - Lifetime
- 1997-12-23 SK SK828-99A patent/SK285088B6/sk not_active IP Right Cessation
- 1997-12-23 CA CA002275596A patent/CA2275596C/en not_active Expired - Fee Related
- 1997-12-23 BR BR9714081-3A patent/BR9714081A/pt not_active Application Discontinuation
- 1997-12-23 WO PCT/FR1997/002393 patent/WO1998028271A1/fr active IP Right Grant
- 1997-12-23 TR TR1999/01363T patent/TR199901363T2/xx unknown
- 1997-12-23 RS YUP-289/99A patent/RS49882B/sr unknown
- 1997-12-23 SI SI9730720T patent/SI0950050T1/sl unknown
- 1997-12-23 HU HU0001387A patent/HU227425B1/hu not_active IP Right Cessation
- 1997-12-23 UY UY24825A patent/UY24825A1/es not_active IP Right Cessation
- 1997-12-23 NZ NZ336130A patent/NZ336130A/xx not_active IP Right Cessation
- 1997-12-23 EG EG138397A patent/EG21567A/xx active
- 1997-12-23 IN IN3761DE1997 patent/IN186976B/en unknown
- 1997-12-23 DK DK97952986T patent/DK0950050T3/da active
-
1998
- 1998-01-21 TW TW086119629A patent/TW518322B/zh not_active IP Right Cessation
- 1998-03-11 SA SA98180971A patent/SA98180971B1/ar unknown
-
1999
- 1999-06-10 IS IS5076A patent/IS2357B/is unknown
- 1999-06-22 NO NO19993076A patent/NO312364B1/no not_active IP Right Cessation
-
2000
- 2000-06-01 HK HK00103287A patent/HK1024002A1/xx not_active IP Right Cessation
-
2009
- 2009-05-07 JP JP2009112971A patent/JP2009197022A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2744010B1 (fr) | Procede de fabrication d'implants osseux | |
FR2708601B1 (fr) | Procédé de cristallisation d'Iopamidol. | |
DZ2032A1 (fr) | Un procédé pour la préparation de l'hydrochlorure de lercanidipine. | |
MA23179A1 (fr) | Procede de preparation d'un monohydrate cristallin d'un spirostanylglycoside | |
FR2764883B1 (fr) | Procede de fabrication d'hydrofluoroalcanes | |
FR2743808B1 (fr) | Procede de preparation de chlorures d'alkyle | |
DZ2383A1 (fr) | Procédé pour la cristallisation d'un dérivé de tétrahydropyridine et formes cristallines ainsi obtenues | |
MA24534A1 (fr) | Procede pour la production d'irones | |
FR2754816B1 (fr) | Procede de purification d'hydrogenochlorofluoroethanes | |
DZ3074A1 (fr) | Formes cristallines du (R)-(+)-N-Ä3-Ä1 berizoyl-3-(3,4-dichlorophényl)pipéridin-3YLÜpropyl-1-YLÜ-4-phénylpipéridin-4-YLÜ-N-méthylacetamide(osanétant) et procédé pour leur préparation. | |
FR2633290B1 (fr) | Procede pour la fabrication de carbamates d'iodoalcynyles | |
MA23081A1 (fr) | Procede de preparation de derives d'indolone | |
FR2755238B1 (fr) | Procede de caracterisation d'un photorepeteur | |
FR2644161B1 (fr) | Procede de preparation d'amides n-arylsubstitues | |
MA22200A1 (fr) | Procede de preparation de derives d'aminodiols | |
FR2729387B1 (fr) | Procede pour la fabrication d'hydroxy-alcoxy-benzophenones | |
FR2602766B1 (fr) | Composes dichlorotrifluoromethylnitrotoluenes et procede de preparation d'aminotrifluoromethyltoluenes a partir de ces composes | |
NO308471B1 (no) | FremgangsmÕter for fremstilling av lorakarbefmonohydrat og krystallinsk anhydratform av lorakarbef | |
FR2615185B1 (fr) | Procede de preparation de trifluoromethyltoluene a partir d'halomethylbenzotrifluorure | |
FR2732154B1 (fr) | Procede de fabrication d'isolateurs | |
FR2757510B1 (fr) | Forme microparticulaire d'un derive de tetrahydropyridine | |
MA23986A1 (fr) | Procede de preparation d'hydrates de phosphate trisodique cristallins | |
MA24258A1 (fr) | Procede de monoacylation d'hydoxytaxanes | |
FR2780736B1 (fr) | Procede de cristallisation d'un materiau semiconducteur et systeme de cristallisation | |
FR2742431B1 (fr) | Procede d'elaboration de granulats de construction a partir de machefers |